Skip to main content
. 2023 Mar 27;15(6):2237–2274. doi: 10.18632/aging.204611

Figure 4.

Figure 4

The surface under the cumulative ranking curve for hemoglobin. (A) placebo/control; (B) ESAs; (C) daprodustat; (D) molidustat; (E) vadadustat; (F) roxadustat; (G) enarodustat.